Publications by authors named "Andrew Fowell"

Claim this Profile
I
Impact of rapid on-site evaluation in expediting the fast investigative lung cancer pathway.
Andrew Fowell, Kashif Khan

Cytopathology· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel, nurse-led early postdischarge clinic is associated with fewer readmissions and lower mortality following hospitalisation with decompensated cirrhosis.
Benjamin Giles, Kirsty Fancey, Karen Gamble, Zeshan Riaz, Joanna K Dowman, Andrew J Fowell

Frontline Gastroenterol· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tandem mass tag-based quantitative proteomic profiling identifies candidate serum biomarkers of drug-induced liver injury in humans.
Kodihalli C Ravindra, Vishal S Vaidya, Zhenyu Wang, Joel D Federspiel, Richard Virgen-Slane, Andrew J Fowell

Nat Commun· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synbiotics Alter Fecal Microbiomes, But Not Liver Fat or Fibrosis, in a Randomized Trial of Patients With Nonalcoholic Fatty Liver Disease.
Eleonora Scorletti, Paul R Afolabi, Elizabeth A Miles, Debbie E Smith, Amal Almehmadi, Andrew J Fowell

Gastroenterology· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a primary to secondary care referral pathway and novel nurse-led one-stop clinic for patients with suspected non-alcoholic fatty liver disease.
Andrew J Fowell, Kirsty Fancey, Karen Gamble, Kelly Bicknell, Joanna K Dowman

Frontline Gastroenterol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Care standards for non-alcoholic fatty liver disease in the United Kingdom 2016: a cross-sectional survey.
David A Sheridan, Guru Aithal, William Alazawi, Michael Allison, Quentin Anstee, Andrew Fowell

Frontline Gastroenterol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel technique for peroral direct cholangioscopy.
Jim L Callaghan, Gaius Longcroft-Wheaton, Andrew J Fowell, Richard D Ellis, Pradeep Bhandari

Endoscopy· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
End of life care in Wales: evaluation of a care pathway-based implementation strategy.
Rosalynde Patricia Johnstone, Angela Jones, Andrew Fowell, Christopher Richard Burton, Jo Rycroft-Malone

BMJ Support Palliat Care· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A polymorphism in IL28B distinguishes exposed, uninfected individuals from spontaneous resolvers of HCV infection.
Susanne Knapp, Usama Warshow, K M Alexander Ho, Doha Hegazy, Ann-Margaret Little, Andrew Fowell

Gastroenterology· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Silencing tissue inhibitors of metalloproteinases (TIMPs) with short interfering RNA reveals a role for TIMP-1 in hepatic stellate cell proliferation.
Andrew J Fowell, Jane E Collins, Dale R Duncombe, Judith A Pickering, William M C Rosenberg

Biochem Biophys Res Commun· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telaprevir: a new hope in the treatment of chronic hepatitis C?
Andrew J Fowell, Kathryn L Nash

Adv Ther· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consistent beneficial effects of killer cell immunoglobulin-like receptor 2DL3 and group 1 human leukocyte antigen-C following exposure to hepatitis C virus.
Susanne Knapp, Usama Warshow, Doha Hegazy, Louise Brackenbury, I Neil Guha, Andrew Fowell

Hepatology· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Renal hepatitis C in the absence of detectable serum or hepatic virus.
Andrew J Fowell, Nicholas Sheron, William M C Rosenberg

Liver Int· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can matrix metalloproteinases be targeted in hepatic ischemia/reperfusion injury?
Andrew J Fowell, R Christopher Benyon

Hepatology· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffuse luminal ulceration resulting from duodenal plasmacytoma.
Andrew J Fowell, David N Poller, Richard D Ellis

Gastrointest Endosc· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reported symptoms in the last days of life: the need for robust research.
Andrew Fowell, Ros Johnstone, Ian Russell, Daphne Russell, Ilora Finlay

Palliat Med· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging therapies for liver fibrosis.
Andrew J Fowell, John P Iredale

Dig Dis· August 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cluster randomisation or randomised consent as an appropriate methodology for trials in palliative care: a feasibility study [ISRCTN60243484].
Andrew Fowell, Ian Russell, Ros Johnstone, Ilora Finlay, Daphne Russell

BMC Palliat Care· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An integrated care pathway for the last two days of life: Wales-wide benchmarking in palliative care.
Andrew Fowell, Ilora Finlay, Ros Johnstone, Lindsey Minto

Int J Palliat Nurs· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis